<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human <z:e sem="disease" ids="C0276912" disease_type="Disease or Syndrome" abbrv="">pythiosis</z:e> is an emerging disease in the tropical, subtropical and temperate regions of the world </plain></SENT>
<SENT sid="1" pm="."><plain>It is caused by the straminipilan, fungus-like, aquatic organism Pythium insidiosum </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0276912" disease_type="Disease or Syndrome" abbrv="">Pythiosis</z:e> occurs in localized as well as systemic or vascular forms </plain></SENT>
<SENT sid="3" pm="."><plain>Most patients with arterial <z:e sem="disease" ids="C0276912" disease_type="Disease or Syndrome" abbrv="">pythiosis</z:e> usually have underlying <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> such as <z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>/<z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) syndrome </plain></SENT>
<SENT sid="4" pm="."><plain>Vascular <z:e sem="disease" ids="C0276912" disease_type="Disease or Syndrome" abbrv="">pythiosis</z:e> is characterized by ascending blood vessel <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and <z:mp ids='MP_0005048'>thrombosis</z:mp> of the major arteries especially those of the lower extremities </plain></SENT>
<SENT sid="5" pm="."><plain>When the <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> reaches a main artery, the patient usually dies within weeks </plain></SENT>
<SENT sid="6" pm="."><plain>Since this pathogen is resistant to most <z:chebi fb="0" ids="35718">antifungal drugs</z:chebi>, immunotherapy was recently used to cure humans and animals with the disease </plain></SENT>
<SENT sid="7" pm="."><plain>A modified P. insidiosum-antigen (PIA) formulation had already saved a young boy with life-threatening arterial <z:e sem="disease" ids="C0276912" disease_type="Disease or Syndrome" abbrv="">pythiosis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Here, we report the therapeutic benefits of the PIA in eight patients with vascular <z:e sem="disease" ids="C0276912" disease_type="Disease or Syndrome" abbrv="">pythiosis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Six of them had <z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> and the other two had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the patients had <z:mp ids='MP_0006134'>arterial occlusion</z:mp> of the lower limbs </plain></SENT>
<SENT sid="11" pm="."><plain>P. insidiosum was isolated and identified by culture and by histopathology </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had evidence of active <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> when immunotherapy began </plain></SENT>
<SENT sid="13" pm="."><plain>After two injections of 100-200 microl of PIA (2.0mg/ml), at a 14-day interval, four patients (50%) had dramatic and complete remission </plain></SENT>
<SENT sid="14" pm="."><plain>Two patients showed partial responses to PIA while the other two did not </plain></SENT>
<SENT sid="15" pm="."><plain>Clinical responses correlated with the immunological reactions at the site of injection, clearance of the arteries and cytokine production </plain></SENT>
<SENT sid="16" pm="."><plain>The latter included the shifting in serum levels of IL4 and IL5 to IL2 suggesting a switching from a T helper 2 (Th2) to a T helper 1 (Th1) subset </plain></SENT>
<SENT sid="17" pm="."><plain>Our findings provide further evidence that immunotherapy using PIA is a safe and effective method to treat <z:e sem="disease" ids="C0276912" disease_type="Disease or Syndrome" abbrv="">pythiosis</z:e> in humans </plain></SENT>
</text></document>